Torrent Pharma, a manufacturer of pharmaceutical products, has reported net sales of INR4.98bn, an increase of 9%, as compared to INR4.56bn in the prior year period.
Subscribe to our email newsletter
The company has reported net profit of INR430m, compared to INR590m during the same period last year.
For FY 2010-11, sales increased 16% to INR21.61bn compared with INR18.67bn for the corresponding last year.
Torrent net profit was INR2.70bn for the FY 2010-11, an increase of 17%, compared to the INR2.31bn during the previous period.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.